null

SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC1=O

InChI Key InChIKey=FHSGULRVYLHXFO-FFNFELIASA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 16 hits for monomerid = 50065453   

TargetSomatostatin receptor type 5(Homo sapiens (Human))
Novartis Pharma

Curated by PDSP Ki Database
LigandPNGBDBM50065453((5S,8S,11S,14R,17S,19aS)-11-(4-Amino-butyl)-5,17-d...)copy SMILEScopy InChI
Affinity DataKi:  0.300nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6BF9PubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Novartis Pharma

Curated by PDSP Ki Database
LigandPNGBDBM50065453((5S,8S,11S,14R,17S,19aS)-11-(4-Amino-butyl)-5,17-d...)copy SMILEScopy InChI
Affinity DataKi:  0.300nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Q23XTWPubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Novartis Pharma

Curated by PDSP Ki Database
LigandPNGBDBM50065453((5S,8S,11S,14R,17S,19aS)-11-(4-Amino-butyl)-5,17-d...)copy SMILEScopy InChI
Affinity DataKi:  0.300nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6BF9PubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Novartis Pharma

Curated by PDSP Ki Database
LigandPNGBDBM50065453((5S,8S,11S,14R,17S,19aS)-11-(4-Amino-butyl)-5,17-d...)copy SMILEScopy InChI
Affinity DataKi:  1.69nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Q23XTWPubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Novartis Pharma

Curated by PDSP Ki Database
LigandPNGBDBM50065453((5S,8S,11S,14R,17S,19aS)-11-(4-Amino-butyl)-5,17-d...)copy SMILEScopy InChI
Affinity DataKi:  1.69nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6BF9PubMed
TargetSomatostatin receptor type 5(RAT)
Sandoz Pharma Ltd.

Curated by PDSP Ki Database
LigandPNGBDBM50065453((5S,8S,11S,14R,17S,19aS)-11-(4-Amino-butyl)-5,17-d...)copy SMILEScopy InChI
Affinity DataKi:  3.23nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XD105RPubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Novartis Pharma

Curated by PDSP Ki Database
LigandPNGBDBM50065453((5S,8S,11S,14R,17S,19aS)-11-(4-Amino-butyl)-5,17-d...)copy SMILEScopy InChI
Affinity DataKi:  20.4nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Q23XTWPubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Novartis Pharma

Curated by PDSP Ki Database
LigandPNGBDBM50065453((5S,8S,11S,14R,17S,19aS)-11-(4-Amino-butyl)-5,17-d...)copy SMILEScopy InChI
Affinity DataKi:  20.4nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6BF9PubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Novartis Pharma

Curated by PDSP Ki Database
LigandPNGBDBM50065453((5S,8S,11S,14R,17S,19aS)-11-(4-Amino-butyl)-5,17-d...)copy SMILEScopy InChI
Affinity DataKi:  20.4nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25H7DTQPubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Novartis Pharma

Curated by PDSP Ki Database
LigandPNGBDBM50065453((5S,8S,11S,14R,17S,19aS)-11-(4-Amino-butyl)-5,17-d...)copy SMILEScopy InChI
Affinity DataKi:  25nMAssay Description:In vitro inhibition of radioligand binding to human Somatostatin receptor type 5 expressed in CHO-K1 cells.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Z60N6XPubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Novartis Pharma

Curated by PDSP Ki Database
LigandPNGBDBM50065453((5S,8S,11S,14R,17S,19aS)-11-(4-Amino-butyl)-5,17-d...)copy SMILEScopy InChI
Affinity DataKi:  39.8nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2WQ02B7PubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Novartis Pharma

Curated by PDSP Ki Database
LigandPNGBDBM50065453((5S,8S,11S,14R,17S,19aS)-11-(4-Amino-butyl)-5,17-d...)copy SMILEScopy InChI
Affinity DataKi:  40nMAssay Description:Binding affinity towards human Somatostatin receptor type 5 (sst5) using Tyr11-[125I]-SRIF as radioligand was determined in COS cellMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CR5X31PubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Novartis Pharma

Curated by PDSP Ki Database
LigandPNGBDBM50065453((5S,8S,11S,14R,17S,19aS)-11-(4-Amino-butyl)-5,17-d...)copy SMILEScopy InChI
Affinity DataKi:  67.6nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Q23XTWPubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Novartis Pharma

Curated by PDSP Ki Database
LigandPNGBDBM50065453((5S,8S,11S,14R,17S,19aS)-11-(4-Amino-butyl)-5,17-d...)copy SMILEScopy InChI
Affinity DataKi:  67.6nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25H7DTQPubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Novartis Pharma

Curated by PDSP Ki Database
LigandPNGBDBM50065453((5S,8S,11S,14R,17S,19aS)-11-(4-Amino-butyl)-5,17-d...)copy SMILEScopy InChI
Affinity DataKi:  1.00E+3nMMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2X065KZPubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Novartis Pharma

Curated by PDSP Ki Database
LigandPNGBDBM50065453((5S,8S,11S,14R,17S,19aS)-11-(4-Amino-butyl)-5,17-d...)copy SMILEScopy InChI
Affinity DataKd:  7.60nMAssay Description:In vitro inhibition of radioligand binding to human Somatostatin receptor type 5 expressed in CCL-39 cells.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Z60N6XPubMed